Patwardhan, P. P., Ivy, K. S., Musi, E., de Stanchina, E., & Schwartz, G. K. (2015). Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma. Oncotarget.
শিকাগো স্টাইলে সাইটেশনPatwardhan, Parag P., Kathryn S. Ivy, Elgilda Musi, Elisa de Stanchina, এবং Gary K. Schwartz. "Significant Blockade of Multiple Receptor Tyrosine Kinases By MGCD516 (Sitravatinib), a Novel Small Molecule Inhibitor, Shows Potent Anti-tumor Activity in Preclinical Models of Sarcoma." Oncotarget 2015.
এমএলএ সাইটেশনPatwardhan, Parag P., et al. "Significant Blockade of Multiple Receptor Tyrosine Kinases By MGCD516 (Sitravatinib), a Novel Small Molecule Inhibitor, Shows Potent Anti-tumor Activity in Preclinical Models of Sarcoma." Oncotarget 2015.